Alterome Therapeutics has named Leonardo Faoro, MD, MBA, Chief Medical Officer (CMO). Immediately prior to joining Alterome, Faoro served in the same capacity at Quanta Therapeutics. Alterome’s Oncology Work There, as in this new position, Faoro focused on development of novel Kirsten rat sarcoma viral oncogene homologue (KRAS) inhibitors. This work dovetails with Alterome’s mission of developing next-generation, small-molecule therapies for cancer treatment. Illustrating that, at Al...